🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, asserting the companies hid potential risks that the pain reliever posed to children's cognitive development.

The court filing follows four weeks after Former President Trump promoted an unproven link between using Tylenol - alternatively called paracetamol - while pregnant and autism in children.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic suggested for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he claimed they "betrayed America by gaining financially from pain and promoting medication ignoring the risks."

Kenvue asserts there is insufficient reliable data linking Tylenol to autism spectrum disorder.

"These corporations lied for decades, deliberately risking millions to line their pockets," the attorney general, from the Republican party, stated.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the reliability of paracetamol and the possible consequences that could have on the health of American women and children."

On its official site, Kenvue also said it had "consistently assessed the applicable studies and there is lacking reliable evidence that indicates a proven link between using paracetamol and autism."

Associations acting on behalf of doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat pain and elevated temperature, which can create major wellness concerns if not addressed.

"In more than two decades of studies on the consumption of paracetamol in pregnancy, no reliable research has successfully concluded that the use of paracetamol in any trimester of pregnancy causes neurodevelopmental disorders in young ones," the association stated.

This legal action mentions latest statements from the previous government in claiming the drug is allegedly unsafe.

Last month, Trump raised alarms from health experts when he told expectant mothers to "resist strongly" not to take Tylenol when ill.

The FDA then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in young ones has not been proven.

Health Secretary RFK Jr, who manages the Food and Drug Administration, had vowed in spring to initiate "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a short period.

But specialists advised that finding a sole reason of autism spectrum disorder - believed by scientists to be the result of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that influences how persons experience and interact with the surroundings, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - aligned with the former president who is seeking US Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the science" around paracetamol and autism.

This legal action attempts to require the firms "eliminate any marketing or advertising" that asserts acetaminophen is safe for pregnant women.

This legal action mirrors the grievances of a collection of parents of minors with autism spectrum disorder and ADHD who filed suit against the producers of Tylenol in recently.

The court dismissed the case, saying research from the family's specialists was inconclusive.